Organicell Regenerative Medicine, Inc. Engages Law Firm McDermott Will & Emery

Author's Avatar
Aug 30, 2022

MIAMI, FL / ACCESSWIRE / August 30, 2022 / Organicell+Regenerative+Medicine%2C+Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company principally focused on the development of innovative regenerative medicine and biological therapeutics, announced today the broad-based engagement of top international law firm McDermott Will & Emery, widely considered to have the best health care practice in the nation.